Dutch medtech market players advised to plan for DRGs - ARCHIVE VERSION
This article was originally published in Clinica
Executive Summary
The Dutch healthcare system is undergoing major financing reform. Medical device manufacturers are expected to be affected by the changes, although the industry will not initially feel the brunt, according to the Dutch Association of Hospitals. It will however be impacted in the coming years, as the pressure grows for the purse holders to keep a tight rein on budgets in a more market-driven system.